Year : 2015 | Volume
| Issue : 1 | Page : 19-22
Modified sevoflurane-based sedation technique versus propofol sedation technique: A randomized-controlled study
Mohamed Ibrahim Syaed El Ahl
Department of Anesthesia, Burjeel Hospital, Abu Dhabi, UAE; Lecturer of Anesthesia, Anesthesia Department, Ain Shams University, Cairo, Egypt
Dr. Mohamed Ibrahim Syaed El Ahl
Department of Anesthesia, Burjeel Hospital, El Najda Street, Abu Dhabi, UAE
Source of Support: None, Conflict of Interest: None
|Date of Web Publication||5-Dec-2014|
Background: The aim of this study was to evaluate the safety and efficacy of sevoflurane-based sedation technique for colonoscopy in geriatric patients as compared with that using propofol. Materials and Methods: Sixty elderly patients, who were scheduled for colonoscopy, participated in this controlled prospective study and were randomly allocated into two groups; P and S. The patients were sedated using either propofol in P group or sevoflurane in S group. Complications (including apnea, the need for airway intervention, occurrence of general anesthesia [GA], hemodynamic instability and others), the fentanyl requirement and the times of the procedure, recovery, and discharge were recorded in both groups. Results: The patients in P group had more frequent apnea attacks, need for airway intervention and occurrence of GA compared to the patients in S group. However, both groups were comparable regarding the other measured variables. Conclusion: For geriatric colonoscopy, sevoflurane can provide safe and effective sedation alternative to propofol.
Keywords: Colonoscopy, sedation, sevoflurane
|How to cite this article:|
Syaed El Ahl MI. Modified sevoflurane-based sedation technique versus propofol sedation technique: A randomized-controlled study. Saudi J Anaesth 2015;9:19-22
|How to cite this URL:|
Syaed El Ahl MI. Modified sevoflurane-based sedation technique versus propofol sedation technique: A randomized-controlled study. Saudi J Anaesth [serial online] 2015 [cited 2021 Oct 18];9:19-22. Available from: https://www.saudija.org/text.asp?2015/9/1/19/146265
| Introduction|| |
The geriatric patients is most rapidly growing age group,  as a result of the parallel decline in mortality and fertility rates.  Even in the absence of any discernible disease, the aging process results in a progressive functional decline in all major systems.  Colonoscopy is one of the most commonly performed outpatient procedures for the diagnosis, serial surveillance, and treatment of gastrointestinal disorders.  It is usually performed under deep sedation using intravenous (IV) sedative and analgesic agents. , The purpose of anesthesia is to provide adequate analgesia, amnesia and control of the patient behavior with a rapid and complete recovery. Propofol, an ultra-short-acting sedative agent, has been used widely for endoscopy. It can provide safe and effective sedation for all gastrointestinal procedures;  However, the related airway obstruction and apnea may be risky, especially in geriatric patients. Sevoflurane (fluorinated methyl isopropyl ether) is a nonpungent inhalational anesthetic with a rapid induction and quick elimination.  Because of these characteristics, sevoflurane was successfully used for sedation.  The aim of this study was to evaluate the safety and efficacy of sevoflurane-based sedation technique for colonoscopy in geriatric patients as compared with that using propofol.
| Materials and Methods|| |
The Ethical Committee of Burjeel Hospital approved this prospective randomized study. Sixty patients (American Society of Anesthesiologists I-II, ≥60 years old), who were scheduled for colonoscopy during a 6-month period (October 2013-March 2014), formed the study group, and their informed written consents were obtained. The patients with body mass index >35 kg/m 2 or obstructive sleep apnea were excluded. The patients were randomly allocated (using closed envelope technique) into two groups; P and S. All patients were sedated using either propofol in P group or sevoflurane in S group.
On arrival to the endoscopy room, an IV line was inserted, the basic standard monitoring lines were applied (non-invasive blood pressure [BP], oxygen saturation [SaPO 2 ], electrocardiogram) and the basal readings were recorded. In both groups, 0.5 mg/kg propofol IV was administered. In P group, a clear plastic mask was applied. In S group, a nasal airway was inserted and connected to a semi-closed anesthesia circuit (Datex-Ohmeda Aespire view) (GE Healthcare3030 Ohmeda Drive P.O. Box 7550 Madison, WI 53707-7550 U.S.A.). A low flow rate of 4 L/min of 100% O 2 was started for both groups. A capnogram sample line was placed under the oxygen mask in P group and connected to the circuit in S group. The sedation was maintained using propofol increments (0.25 mg/kg) in P group and with sevoflurane (started at 1%) in S group. The sevoflurane concentration and the frequency of propofol increment injection were adjusted to achieve a sedation level 3 of observer alertness assessment score (OAAS) [Table 1]. Fentanyl 25 mcg supplementation was used in the event of pain.
Apnea, the need for airway intervention, the occurrence of general anesthesia (GA) and other complications (laryngospasm, oxygen desaturation, and postoperative nausea and vomiting [PONV]) were recorded. The mean arterial blood pressure (MBP), heart rate, SaPO 2 and respiratory rate (RR) were recorded at four intervals; baseline, insertion of colonoscope, cannulation of the cecum, and at the end of the procedure. The fentanyl requirement and the times of the procedure, recovery, and discharge were also recorded. Apnea was defined as a lack of spontaneous respiratory effort for 20 s, detected by visual monitoring and capnogram. Airway intervention was defined as any action taken to improve and/or restore ventilation including; jaw thrust, insertion of nasal or oral airway, and ventilatory-assist maneuvers. The airway intervention was undertaken on the judgment of the operator anesthetist. When unarousable, the patient was considered to have GA. Oxygen desaturation was defined as SaPO 2 <90% for >60 s. The procedure time was defined as the time between colonoscope insertion and withdrawal. The recovery and discharge times were defined as the time between withdrawal of the colonoscope until postanesthesia care unit (PACU) transfer (OAAS = 5) and until the patient discharge from PACU (ability to walk unassisted), respectively.
Based on previous results (dd), a sample size estimate was calculated. A study comprised of 20 patients per group, and a P = 0.05 was determined to have a 0.95 power at two tail alpha of 0.05. Data is given as mean (standard deviation). Statistical comparisons between the two groups were performed using Student's t-test for normally distributed data; proportions were analyzed by Fisher's exact test. A two-sided error level of P < 0.05 was considered statistically significant. All statistics were analyzed using a statistical software package (GraphPad InStat, version 3.00 for Windows; GraphPad Software Inc., San Diego, California, USA).
| Results|| |
One patient in each group was excluded for poor bowel preparation while the other 58 patients completed the study [Table 2]. The patients in P group had more frequent apnea attacks, need for airway intervention, and occurrence of GA compared to the patients in S group [Figure 1]. The other complications (including laryngospasm, nausea, vomiting, oxygen desaturation, and significant change of MBP, heart rate, and RR) were infrequent and comparable in both groups [Figure 2] and [Figure 3]. Both groups were also comparable as regarding the fentanyl requirements [Figure 3], procedural time, recovery time, and discharge time [Table 2].
|Figure 1: The frequancies of apnea, occurrence of general anesthesia and need for airway intervention (*Significant values)|
Click here to view
|Figure 2: The vital date: No significant difference regarding the mean arterial pressure (a), oxygen saturation (b), respiratory rate (c) and heart rate (d) at the four measured intervals|
Click here to view
|Figure 3: Frequency of other complications. PONV: Postoperative nausea and vomiting; RR: Respiratory rate; SaPO2: Arterial oxygen saturation|
Click here to view
| Discussion|| |
The purpose of this study was to evaluate the safety and efficacy of a modified sevoflurane-based sedation technique for colonoscopy in geriatric patients. The safety was assessed by the frequency of apnea, degree of desaturation, the need for airway intervention and occurrence of GA, laryngospasm, and the hemodynamic instability. The effectiveness was determined by the ability to achieve grade 3 OAAS with early recovery and discharge.
The elderly population represents a heterogeneous group of individuals with widely variable functional and reserve capacities. Aging is associated with a gradual deterioration of organ function furthermore, in some patients, there is a wide disparity between their chronologic and physiologic ages.  The patients' safety is of utmost and important priority during anesthesia and/or sedation. Many sedation techniques have been described for colonoscopy.  Sevoflurane sedation has been used safely during administration of regional or local anesthesia;  however, to our knowledge, it has not been used for colonoscopy yet. Propofol is considered as the standard agent for sedation in colonoscopy. Compared to other traditional sedative agents, propofol can provide an adequate depth of sedation with rapid recovery, high postanesthesia recovery score, and good patient cooperation.  It also decreases the incidence of PONV and improves the patient's satisfaction.  Therefore, propofol sedation has been considered as a safe technique that can be administered by nurses under physician-endoscopist monitoring.
In this study; the apnea, occurrence of GA and the need for airway intervention were more frequent with the use of propfol than that with sevoflurane. This difference may be due that propofol lacks any analgesic activity and so a high dose is required to perform a painful procedure.  This usually results in a deep level of sedation, respiratory and cardiac depressions.  When propofol sedation is administered by nonanesthesia personnel, the incidence of occurrence of GA (or a deeper sedation level) may reach up to 88%. This increases the risk of respiratory depression, airway obstruction, and hemodynamic instability.  The use of propofol may be also associated with oxygen desaturation (SapO 2 ≤90%) which incidence may reach 9%. The use of supplemental oxygen delays the occurrence of hypoxemia and consequently the detection of apnea during which the CO 2 level may rise to a dangerous level.  Therefore the CO 2 monitoring is important to allow early detection and intervention; however, its exact value is false low (because of dilution occurring in the nasopharynx and under the open O 2 mask).  In this study, both groups were comparable as regards the hemodynamics stability. In contrast, some studies showed that propofol was associated with significant hypotension (BP decrease >20 mmHg) in 27% of patients.  Even a very low dose of propofol (0.4 mg/kg) was associated with 17 mmHg decrease in BP.  This may be attributed to a combination of decreases in basal sympathetic nerve activity (SNA) and in the reflex control of SNA.  Minimizing the sedation recovery time may improve acceptance of colonoscopy use for cancer screening and prevention.  In this study, both group had a comparable the recovery and discharge times.
All the above drawbacks may have more serious consequences in geriatric patients (with associated co-morbidities) and supportive intervention may be necessary. In spite of the sevoflurane safety, it was delivered using a nasal airway which is a convenient way and well tolerated. However carful insertion is required.
| Conclusion|| |
In colonoscopy, sevoflurane can provide safe and effective sedation alternative to propofol.
| References|| |
White PF, White LM, Monk T, Jakobsson J, Raeder J, Mulroy MF, et al
. Perioperative care for the older outpatient undergoing ambulatory surgery. Anesth Analg 2012;114:1190-215.
Lutz W, Sanderson W, Scherbov S. The coming acceleration of global population ageing. Nature 2008;451:716-9.
Schutz SM, Lee JG, Schmitt CM, Almon M, Baillie J. Clues to patient dissatisfaction with conscious sedation for colonoscopy. Am J Gastroenterol 1994;89:1476-9.
Fanti L, Testoni PA. Sedation and analgesia in gastrointestinal endoscopy: What's new? World J Gastroenterol 2010; 16:2451-7.
Ladas SD, Satake Y, Mostafa I, Morse J. Sedation practices for gastrointestinal endoscopy in Europe, North America, Asia, Africa and Australia. Digestion 2010;82:74-6.
Amornyotin S, Srikureja W, Chalayonnavin W, Kongphlay S. Dose requirement and complications of diluted and undiluted propofol for deep sedation in endoscopic retrograde cholangiopancreatography. Hepatobiliary Pancreat Dis Int 2011;10:313-8.
Ibrahim AE, Ghoneim MM, Kharasch ED, Epstein RH, Groudine SB, Ebert TJ, et al
. Speed of recovery and side-effect profile of sevoflurane sedation compared with midazolam. Anesthesiology 2001;94:87-94.
Sdrales LM, Miller RD. Elderly patients. In: Sdrales LM, Miller RD, editors. Anesthesia Review: A Study Guide to Anesthesia. 5 th
ed. Philadelphia, PA: Churchill-Livingstone; 2001. p. 407-18.
Froehlich F, Thorens J, Schwizer W, Preisig M, Köhler M, Hays RD, et al
. Sedation and analgesia for colonoscopy: Patient tolerance, pain, and cardiorespiratory parameters. Gastrointest Endosc 1997;45:1-9.
Chen SC, Rex DK. Review article: Registered nurse-administered propofol sedation for endoscopy. Aliment Pharmacol Ther 2004;19:147-55.
Ramsay MA, Newman KB, Jacobson RM, Richardson CT, Rogers L, Brown BJ, et al
. Sedation levels during propofol administration for outpatient colonoscopies. Proc (Bayl Univ Med Cent) 2014;27:12-5.
Rex DK. Review article: moderate sedation for endoscopy: Sedation regimens for non-anaesthesiologists. Aliment Pharmacol Ther 2006;24:163-71.
Cohen LB, Dubovsky AN, Aisenberg J, Miller KM. Propofol for endoscopic sedation: A protocol for safe and effective administration by the gastroenterologist. Gastrointest Endosc 2003;58:725-32.
Sato J, Saito S, Jonokoshi H, Nishikawa K, Goto F. Correlation and linear regression between blood pressure decreases after a test dose injection of propofol and that following Anesthesia induction. Anesthesia Intensive Care 2003;31:523-8.
Leung FW, Aljebreen AM, Brocchi E, Chang EB, Liao WC, Mizukami T, et al
. Sedation-risk-free colonoscopy for minimizing the burden of colorectal cancer screening. World J Gastrointest Endosc 2010;2:81-9.
Bright E, Roseveare C, Dalgleish D, Kimble J, Elliott J, Shepherd H. Patient-controlled sedation for colonoscopy: A randomized trial comparing patient-controlled administration of propofol and alfentanil with physician-administered midazolam and pethidine. Endoscopy 2003;35:683-7.
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2]